The Economic Burden of Bipolar Disorder in the United States: A Systematic Literature Review
Open accessThe DOI matches its Crossref record; 79 of the 79 references it cites were found in a registry or an index.
Abstract
Bipolar disorder (BD) is a mood disorder with subtypes characterized by episodes of mania, hypomania, and/or depression. BD is associated with substantial economic burden, and the bipolar I disorder (BD-I) subtype is associated with high medical costs. This review further evaluated the economic burden of BD and BD-I in the United States (US), describing health-care resource utilization (HCRU) and sources of direct medical and indirect costs. Data were obtained from systematic searches of MEDLINE ® , EMBASE ® , and National Health Service Economic Evaluation Database. Citations were screened to identify primary research studies (published 2008– 2018) on the economic burden of BD/BD-I or its treatment in real-world settings. Reported costs were converted to 2018 US dollars. Of identified abstracts (N=4111), 56 studies were included. The estimated total annual national economic burden of BD/BD-I was more than $195 billion, with approximately 25% attributed to direct medical costs. Individuals with BD/BD-I used health-care services more frequently and had higher direct medical costs than matched individuals without the disease. Drivers of higher direct costs included frequent psychiatric interventions, presence of comorbid medical/psychiatric conditions, and both suboptimal medication adherence and clinical management. Indirect costs (eg, unemployment, lost work productivity for patients/caregivers) accounted for 72– 80% of the national economic burden of BD/BD-I. Different definitions for study populations and cost categories limited comparisons of economic outcomes. This review builds on existing literature describing the economic burden of BD and confirmed cost drivers of BD/BD-I. Improved clinical management of BD/BD-I and associated comorbidities, together with better medication adherence, may reduce health-care costs and improve patient outcomes. Keywords: cost of illness, health care costs, indirect costs, mania, mood disorder, resource utilization
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
American Psychiatric Association (2013) · doi:10.1176/appi.books.9780890425596 · Cited by 116,369
Economic Costs of Diabetes in the U.S. in 2002
American Diabetes Association (2003) · Diabetes Care · doi:10.2337/diacare.26.3.917 · Cited by 4,147
Prevalence and Correlates of Bipolar Spectrum Disorder in the World Mental Health Survey Initiative
Merikangas, K. R., Jin, R., He, J.-P., Kessler, R. C., Lee, S., Sampson, N. A., Viana, M. C., Andrade, L. H., Hu, C., Karam, E. G., et al. (2011) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.12 · Cited by 2,627
Economic Costs of Diabetes in the U.S. in 2017
American Diabetes Association (2018) · Diabetes Care · doi:10.2337/dci18-0007 · Cited by 2,528
Estimating the true global burden of mental illness
Vigo, D., Thornicroft, G., & Atun, R. (2016) · The Lancet Psychiatry · doi:10.1016/s2215-0366(15)00505-2 · Cited by 2,494
Merikangas, K. R., Akiskal, H. S., Angst, J., Greenberg, P. E., Hirschfeld, R. M. A., Petukhova, M., & Kessler, R. C. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.5.543 · Cited by 2,399
Yatham, L. N., Kennedy, S. H., Parikh, S. V., Schaffer, A., Bond, D. J., Frey, B. N., Sharma, V., Goldstein, B. I., Rej, S., Beaulieu, S., et al. (2018) · Bipolar Disorders · doi:10.1111/bdi.12609 · Cited by 1,852
Goodwin, G., Haddad, P., Ferrier, I., Aronson, J., Barnes, T., Cipriani, A., Coghill, D., Fazel, S., Geddes, Jr., Grunze, H., et al. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116636545 · Cited by 1,309
Vieta, E., Berk, M., Schulze, T. G., Carvalho, A. F., Suppes, T., Calabrese, J. R., Gao, K., Miskowiak, K. W., & Grande, I. (2018) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2018.8 · Cited by 891
Malhi, G. S., Bassett, D., Boyce, P., Bryant, R., Fitzgerald, P. B., Fritz, K., Hopwood, M., Lyndon, B., Mulder, R., Murray, G., et al. (2015) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867415617657 · Cited by 842
Judd, L. L., Akiskal, H. S., Schettler, P. J., Endicott, J., Leon, A. C., Solomon, D. A., Coryell, W., Maser, J. D., & Keller, M. B. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.12.1322 · Cited by 577
Vancampfort, D., Vansteelandt, K., Correll, C. U., Mitchell, A. J., De Herdt, A., Sienaert, P., Probst, M., & De Hert, M. (2013) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2012.12050620 · Cited by 441
An economic evaluation of manic-depressive illness-1991
Wyatt, R. J., & Henter, I. (1995) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/bf00789056 · Cited by 312
The Lifetime Cost of Bipolar Disorder in the US: An Estimate for New Cases in 1998
Begley, C. E., Annegers, J. F., Swann, A. C., Lewis, C., Coan, S., Schnapp, W. B., & Bryant-Comstock, L. (2001) · PharmacoEconomics · doi:10.2165/00019053-200119050-00004 · Cited by 265 · cited 1×
“For example, one analysis estimated the per-person total lifetime costs of BD in the US ranged from $11,720 for a single manic episode to $624,785 for a disease course marked by nonresponsive/ chronic episodes (1998 US dollars [USD]).(9) Sources of direct health-care costs for individuals with BD include medical expen…”
BackgroundFountoulakis, K. N., Grunze, H., Vieta, E., Young, A., Yatham, L., Blier, P., Kasper, S., & Moeller, H. J. (2016) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyw109 · Cited by 248
Rhee, T. G., Olfson, M., Nierenberg, A. A., & Wilkinson, S. T. (2020) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2020.19091000 · Cited by 244
An estimate of the minimum economic burden of bipolar I and II disorders in the United States: 2009
Dilsaver, S. C. (2011) · Journal of Affective Disorders · doi:10.1016/j.jad.2010.08.030 · Cited by 226
The economic burden of bipolar I disorder in the United States in 2015
Cloutier, M., Greene, M., Guerin, A., Touya, M., & Wu, E. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2017.09.011 · Cited by 215
Functional Impairment and Disability across Mood States in Bipolar Disorder
Rosa, A. R., Reinares, M., Michalak, E. E., Bonnin, C. M., Sole, B., Franco, C., Comes, M., Torrent, C., Kapczinski, F., & Vieta, E. (2010) · Value in Health · doi:10.1111/j.1524-4733.2010.00768.x · Cited by 208
Cardiovascular mortality in bipolar disorder: a population-based cohort study in Sweden
Westman, J., Hällgren, J., Wahlbeck, K., Erlinge, D., Alfredsson, L., & Ösby, U. (2013) · BMJ Open · doi:10.1136/bmjopen-2012-002373 · Cited by 204
Factors associated with treatment nonadherence among US bipolar disorder patients
Baldessarini, R. J., Perry, R., & Pike, J. (2008) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.908 · Cited by 198
Grunze, H., Vieta, E., Goodwin, G. M., Bowden, C., Licht, R. W., Azorin, J.-M., Yatham, L., Mosolov, S., Möller, H.-J., Kasper, S., et al. (2018) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2017.1384850 · Cited by 187
Kemp, D. E., Gao, K., Chan, P. K., Ganocy, S. J., Findling, R. L., & Calabrese, J. R. (2010) · Bipolar Disorders · doi:10.1111/j.1399-5618.2010.00823.x · Cited by 177
Baldessarini, R., Henk, H., Sklar, A., Chang, J., & Leahy, L. (2008) · Psychiatric Services · doi:10.1176/appi.ps.59.10.1175 · Cited by 173
Goldstein, B. I., Liu, S.-M., Zivkovic, N., Schaffer, A., Chien, L.-C., & Blanco, C. (2011) · Bipolar Disorders · doi:10.1111/j.1399-5618.2011.00932.x · Cited by 172
A systematic review of the evidence of the burden of bipolar disorder in Europe
Fajutrao, L., Locklear, J., Priaulx, J., & Heyes, A. (2009) · Clinical Practice and Epidemiology in Mental Health · doi:10.1186/1745-0179-5-3 · Cited by 162
Blanco, C., Compton, W. M., Saha, T. D., Goldstein, B. I., Ruan, W. J., Huang, B., & Grant, B. F. (2017) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2016.10.003 · Cited by 149
Behavioral Health Parity and the Affordable Care Act
Frank, R. G., Beronio, K., & Glied, S. A. (2014) · Journal of Social Work in Disability & Rehabilitation · doi:10.1080/1536710x.2013.870512 · Cited by 129
Cost of illness for bipolar disorder: a systematic review of the economic burden
Kleine‐Budde, K., Touil, E., Moock, J., Bramesfeld, A., Kawohl, W., & Wulf Rössler, A. (2013) · Bipolar Disorders · doi:10.1111/bdi.12165 · Cited by 123
The Diagnosis and Management of Bipolar I and II Disorders: Clinical Practice Update
Bobo, W. V. (2017) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2017.06.022 · Cited by 118
Perlis, R. H., Ostacher, M. J., Miklowitz, D. J., Hay, A., Nierenberg, A. A., Thase, M. E., & Sachs, G. S. (2010) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.09m05514yel · Cited by 112
Stensland, M., Watson, P. R., & Grazier, K. L. (2012) · Psychiatric Services · doi:10.1176/appi.ps.201100402 · Cited by 111
Bipolar disorders in DSM-5: strengths, problems and perspectives
Angst, J. (2013) · International Journal of Bipolar Disorders · doi:10.1186/2194-7511-1-12 · Cited by 104
Moreno, C., Hasin, D. S., Arango, C., Oquendo, M. A., Vieta, E., Liu, S., Grant, B. F., & Blanco, C. (2012) · Bipolar Disorders · doi:10.1111/j.1399-5618.2012.01009.x · Cited by 92
Severity of mood symptoms and work productivity in people treated for bipolar disorder
Simon, G. E., Ludman, E. J., Unützer, J., Operskalski, B. H., & Bauer, M. S. (2008) · Bipolar Disorders · doi:10.1111/j.1399-5618.2008.00581.x · Cited by 86
Correll, C. U., Ng-Mak, D. S., Stafkey-Mailey, D., Farrelly, E., Rajagopalan, K., & Loebel, A. (2017) · Annals of General Psychiatry · doi:10.1186/s12991-017-0133-7 · Cited by 79 · cited 1×
“Those with one or more cardiometabolic conditions (vs none) had an increased likelihood of hospital readmission in the 30 days post-discharge, higher costs, longer lengths of stay, and higher in-hospital mortality.(50) Centorrino et al reported that individuals with BD had significantly more metabolic comorbidities th…”
BackgroundO’Donnell, L. A., Deldin, P. J., Grogan‐Kaylor, A. C., McInnis, M. G., Weintraub, J., Ryan, K. A., & Himle, J. A. (2017) · Journal of Affective Disorders · doi:10.1016/j.jad.2017.03.015 · Cited by 75
Lage, M. J., & Hassan, M. K. (2009) · Annals of General Psychiatry · doi:10.1186/1744-859x-8-7 · Cited by 71
Health and Economic Burden of Metabolic Comorbidity Among Individuals With Bipolar Disorder
Centorrino, F., Mark, T. L., Talamo, A., Oh, K., & Chang, J. P. (2009) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e3181bef8a6 · Cited by 70
Shippee, N. D., Shah, N. D., Williams, M. D., Moriarty, J. P., Frye, M. A., & Ziegenfuss, J. Y. (2011) · Health and Quality of Life Outcomes · doi:10.1186/1477-7525-9-90 · Cited by 68
Hassan, M., & Lage, M. J. (2009) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp080374 · Cited by 67
Lindamer, L. A., Liu, L., Sommerfeld, D. H., Folsom, D. P., Hawthorne, W., Garcia, P., Aarons, G. A., & Jeste, D. V. (2012) · Administration and Policy in Mental Health and Mental Health Services Research · doi:10.1007/s10488-011-0350-3 · Cited by 65
Gianfrancesco, F. D., Sajatovic, M., Rajagopalan, K., & Wang, R. (2008) · Clinical Therapeutics · doi:10.1016/s0149-2918(08)80062-8 · Cited by 58
Cost-of-Illness Studies for Bipolar Disorder: Systematic Review of International Studies
Jin, H., & McCrone, P. (2015) · PharmacoEconomics · doi:10.1007/s40273-014-0250-y · Cited by 52 · cited 4×
“The objective of this systematic review is to provide an updated report of the economic burden of BD in the US, including a broader spectrum of cost and/or health-care resource use (HCRU) estimates compared with previous reviews.(6,10) Direct and indirect costs of the disorder are summarized, and drivers of these cost…”
BackgroundMethodInfluentialLang, K. M., Korn, J. R., Muser, E., Choi, J. C., Abouzaid, S., & Menzin, J. (2011) · Journal of Medical Economics · doi:10.3111/13696998.2011.562265 · Cited by 52
Guo, J. J., Keck, P. E., Li, H., Jang, R., & Kelton, C. M. L. (2008) · Value in Health · doi:10.1111/j.1524-4733.2007.00287.x · Cited by 51
Stensland, M. D., Schultz, J. F., & Frytak, J. R. (2008) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v69n0508 · Cited by 50
Peters, A. T., West, A. E., Eisner, L. R., Baek, J., & Deckersbach, T. (2015) · The Journal of Nervous and Mental Disease · doi:10.1097/nmd.0000000000000425 · Cited by 49
McMorris, B. J., Downs, K. E., Panish, J. M., & Dirani, R. D. (2009) · Journal of Medical Economics · doi:10.3111/13696990903475833 · Cited by 47
Effect of First Episode Axis I Disorders on Quality of Life
Rubio, J. M., Olfson, M., Pérez-Fuentes, G., Garcia-Toro, M., Wang, S., & Blanco, C. (2014) · Journal of Nervous & Mental Disease · doi:10.1097/nmd.0000000000000117 · Cited by 42
Busch, A. B., Yoon, F. B., Barry, C. L., Azzone, V., Normand, S. T., Goldman, H. H., & Huskamp, H. A. (2013) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2012.12030392 · Cited by 41
Williams, M. D., Shah, N. D., Wagie, A. E., Wood, D. L., & Frye, M. A. (2011) · Psychiatric Services · doi:10.1176/ps.62.9.pss6209_1073 · Cited by 39
Rascati, K. L., Richards, K. M., Ott, C. A., Goddard, A. W., Stafkey-Mailey, D., Alvir, J. M., Sanders, K. N., & Mychaskiw, M. A. (2011) · Psychiatric Services · doi:10.1176/ps.62.9.pss6209_1032 · Cited by 38
Kilbourne, A. M., Barbaresso, M. M., Lai, Z., Nord, K. M., Bramlet, M., Goodrich, D. E., Post, E. P., Almirall, D., & Bauer, M. S. (2017) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.15m10301 · Cited by 38
Brooks, J. O., Goldberg, J. F., Ketter, T. A., Miklowitz, D. J., Calabrese, J. R., Bowden, C. L., & Thase, M. E. (2010) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.09m05214yel · Cited by 34
Integrating Bipolar Disorder Management in Primary Care
Kilbourne, A. M., Goodrich, D. E., O’Donnell, A. N., & Miller, C. J. (2012) · Current Psychiatry Reports · doi:10.1007/s11920-012-0325-4 · Cited by 33
Role of Adverse Effects in Medication Nonadherence in Bipolar Disorder
Mago, R., Borra, D., & Mahajan, R. (2014) · Harvard Review of Psychiatry · doi:10.1097/hrp.0000000000000017 · Cited by 33
Indirect costs associated with nonadherence to treatment for bipolar disorder
Bagalman, E., Yu-Isenberg, K. S., Durden, E., Crivera, C., Dirani, R., & Bunn, W. B. (2010) · Journal of Occupational & Environmental Medicine · doi:10.1097/jom.0b013e3181db811d · Cited by 32
Seabury, S. A., Goldman, D. P., Kalsekar, I. D., Sheehan, J. J., Laubmeier, K. K., & Lakdawalla, D. (2014) · PubMed · Cited by 32
Ostacher, M. J., Tandon, R., & Suppes, T. (2016) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.15cs09841 · Cited by 27
Depression diagnoses following the identification of bipolar disorder: costly incongruent diagnoses
Stensland, M. D., Schultz, J. F., & Frytak, J. R. (2010) · BMC Psychiatry · doi:10.1186/1471-244x-10-39 · Cited by 27
Chessick, C. A., PERLICK, D. A., Miklowitz, D. J., Dickinson, L. M., Allen, M. H., Morris, C. D., Gonzalez, J. M., Marangell, L. B., Cosgrove, V. E., Ostacher, M. J., et al. (2009) · Bipolar Disorders · doi:10.1111/j.1399-5618.2009.00765.x · Cited by 26
Costs associated with attempted suicide among individuals with bipolar disorder.
Stensland, M. D., Zhu, B., Ascher‐Svanum, H., & BALL, D. E. (2010) · PubMed · Cited by 23
Lum, T. Y. S., Parashuram, S., Shippee, T. P., Wysocki, A., Shippee, N. D., Homyak, P., Kane, R. L., & Williamson, J. B. (2012) · The Gerontologist · doi:10.1093/geront/gns163 · Cited by 22 · cited 1×
“The authors reported a similar pattern for individuals who resided in Medicaidpaid institutional (eg, nursing home) long-term care facilities, noting the increased medication costs relative to those with other mental health diagnoses were expected due to this population’s greater reliance on pharmacotherapy and having…”
BackgroundKim, E., You, M. S., Pikalov, A., Van-Tran, Q., & Jing, Y. (2011) · BMC Psychiatry · doi:10.1186/1471-244x-11-6 · Cited by 21
Jing, Y., Kim, E., You, M. S., Pikalov, A., & Tran, Q.-V. (2009) · Journal of Medical Economics · doi:10.3111/13696990903044092 · Cited by 20
Integrated Pharmacies at Community Mental Health Centers: Medication Adherence and Outcomes
Wright, W. A., Gorman, J. M., Odorzynski, M., Peterson, M. J., & Clayton, C. (2016) · Journal of Managed Care & Specialty Pharmacy · doi:10.18553/jmcp.2016.16004 · Cited by 20 · cited 2×
“Collaborative care of this kind has the potential to reduce the need for acute, intensive, or emergency health-care interventions by providing better continuity of care, while simultaneously reducing the indirect costs of BD and improving patients’ lives.(75) Our review should be considered in context of its limitatio…”
BackgroundBagalman, E., Muser, E., Choi, J. C., Durden, E., Macfadden, W., Haskins, J. T., & Dirani, R. D. (2011) · Clinical Therapeutics · doi:10.1016/j.clinthera.2011.09.005 · Cited by 13
Durden, E., Bagalman, E., Muser, E., Choi, J. C., Crivera, C., Dirani, R. D., Macfadden, W., & Haskins, J. T. (2010) · Journal of Medical Economics · doi:10.3111/13696998.2010.531828 · Cited by 13
Impact of bipolar disorder on the family: utilization and cost of health care resources.
Chatterton, M. L., Ke, X., Lewis, B. E., Rajagopalan, K., & Lazarus, A. L. (2008) · PubMed · Cited by 12
Robertson, A. G., Swanson, J. W., Lin, H., Easter, M. M., Frisman, L. K., & Swartz, M. S. (2015) · Psychiatric Services · doi:10.1176/appi.ps.201500134 · Cited by 10
Qiu, Y., Fu, A. Z., Liu, G. G., & Christensen, D. B. (2010) · Applied Health Economics and Health Policy · doi:10.2165/11318830-000000000-00000 · Cited by 7
Petrila, J. P., Andel, R., Constantine, R. J., & Robst, J. M. (2010) · Psychiatric Services · doi:10.1176/appi.ps.61.5.516 · Cited by 7 · cited 2×
“Direct Non-Health-Care Costs Criminal Justice System There were two studies (both in BD-I populations) that reported incremental costs of BD to the criminal justice system, such as costs of incarceration, policing, and legal costs.(60,61) In a patient survey, employees with BD-I were more likely to report having been…”
BackgroundTohen, M. F., Ng‐Mak, D., Rajagopalan, K., Halpern, R., Chuang, C.-C., & Loebel, A. D. (2017) · The Primary Care Companion For CNS Disorders · doi:10.4088/pcc.16m02066 · Cited by 7
Self-citationQiu, Y., Christensen, D. B., Fu, A. Z., & Liu, G. G. (2008) · Current Medical Research and Opinion · doi:10.1185/03007990802634077 · Cited by 6
Haskins, J. T., Macfadden, W., Turner, N., Crivera, C., Dirani, R. D., Alphs, L. D., Gersing, K. R., & Burchett, B. M. (2010) · Journal of Medical Economics · doi:10.3111/13696998.2010.511064 · Cited by 5
Collaborative Care for Patients With a Bipolar Disorder: A Primary Care FQHC-CMHC Partnership
Kern, J. S., & Cerimele, J. M. (2019) · Psychiatric Services · doi:10.1176/appi.ps.201900019 · Cited by 5
Petrila, J. P., Andel, R., Constantine, R. J., et al. (2010) · Psychiatric Services · doi:10.1176/ps.2010.61.5.516 · Cited by 4
Bipolar Disorder Healthcare Costs for Quetiapine Extended-Release Versus Aripiprazole
Pelletier, E. M., Hassan, M., Alemayehu, B., Smith, M. D., & Kim, P. A. J. (2013) · The American Journal of Managed Care · Cited by 2
Research works printed but not linked: 7
- Rhee, 2020, Am J Psychiatry, appiajp202019091000
- Baldessarini, 2008, Psychiatr Serv, 59, 1175, 10.1176/ps.2008.59.10.1175 · DOI · Paper page
- Pelletier, 2013, Am J Pharm Benefits, 5, e73
- Chatterton, 2008, P T, 33, 15
- Wright, 2016, J Manag Care Spec Pharm, 22, 1330
- Stensland, 2010, J Ment Health Policy Econ, 13, 87
- Seabury, 2014, Am J Manag Care, 20, e52
Cited by
Singh, B., Swartz, H. A., Barboza, A. B. C., Schaffer, A., Kato, T., Dols, A., Sperry, S. H., Vassilev, A. B., Burdick, K. E., & Frye, M. A. (2025) · The Lancet · doi:10.1016/s0140-6736(25)01140-7 · Cited by 133
Yildiz, A., Siafis, S., Mavridis, D., Vieta, E., & Leucht, S. (2023) · The Lancet Psychiatry · doi:10.1016/s2215-0366(23)00199-2 · Cited by 104
A Public Health Perspective of Post-Traumatic Stress Disorder
Jowf, G. I. A., Ahmed, Z. T., An, N., Reijnders, R. A., Ambrosino, E., Rutten, B. P. F., de Nijs, L., & Eijssen, L. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19116474 · Cited by 112
“Nearly all previous researchers found that indirect cost weighs similar or more in magnitude in the overall economic burden than direct costs [31,33,34].”
BackgroundThe burden of anxiety among a nationally representative US adult population
Kavelaars, R., Ward, H. E., Mackie, D. S., Modi, K., & Mohandas, A. (2023) · Journal of Affective Disorders · doi:10.1016/j.jad.2023.04.069 · Cited by 64
Rathour, D., Shah, S., Khan, S., Singh, P. K., Srivastava, S., Singh, S. B., & Khatri, D. K. (2022) · Behavioural Brain Research · doi:10.1016/j.bbr.2022.114081 · Cited by 61
Metadata
- Authors
- Bessonova, L., Ogden, K., Doane, M. J., O'Sullivan, A. K., & Tohen, M.
- Affiliations
- Alkermes (United States) (US)
- Worldwide Clinical Trials (United States) (US)
- University of New Mexico (US)
- Corresponding author
- Bessonova, Leona
- Venue
- ClinicoEconomics and Outcomes Research
- Publisher
- Informa UK Limited
- Published
- 2020-09
- Volume
- Volume 12
- Pages
- 481-497
- ISSN
- 1178-6981 (ISSN-L)
- PMC
- PMC7489939
- OpenAlex
- W3083267042
- Semantic Scholar
- 4b10052566feb7dd1f10943dfd9f816c3f7583ab
- Cited by
- 147
- References
- 78
- Citations by year
- 2026: 19 · 2025: 29 · 2024: 29 · 2023: 29 · 2022: 28 · 2021: 12 · 2020: 1
- FWCI
- 2.90
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- ClinicoEconomics and Outcomes Research (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Dove Medical Press (Taylor and Francis Group) (submittedVersion, cc-by-nc)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
- Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
- Keywords
- bipolar disorder, bipolar I disorder, economic burden, healthcare resource utilization, direct medical costs, indirect costs, productivity loss, medication adherence, comorbidities, mania, mood disorders, United States
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.